Analystreport

Pacira Pharmaceuticals Inc (NASDAQ: PCRX) was upgraded by analysts at Needham & Company LLC to a "buy" rating.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com